Lineamientos para la prevención y el tratamiento de la osteoporosis inducida por glucocorticoides en pediatría / Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis in pediatrics

Objetivo. Proporcionar un marco para profesionales de la salud que tratan a pacientes pediátricos bajo terapia con glucocorticoides (GC) y desarrollar recomendaciones para la prevención y el tratamiento de la osteoporosis inducida por GC en la población pediátrica. Métodos. Un panel de expertos en enfermedades óseas y pediátricas generó una serie de preguntas PICO que abordan aspectos relacionados con la prevención y el tratamiento de osteoporosis en pacientes bajo tratamiento con GC. Siguiendo la metodología GRADE, se realizó una revisión sistemática de la literatura, se resumieron las estimaciones del efecto y se calificó la calidad de la evidencia. Luego se procedió a la votación y a la formulación de las recomendaciones. Resultados. Se desarrollaron 7 recomendaciones y 6 principios generales para osteoporosis inducida por GC en población pediátrica. Conclusión. Estas recomendaciones proporcionan orientación para los médicos que deben tomar decisiones en pacientes pediátricos bajo tratamiento con GC.

Objective. To provide a framework for healthcare professionals managing pediatric patients who are on active glucocorticoid (GC) therapy and to develop recommendations for the prevention and treatment of GC-induced osteoporosis in the pediatric population. Methods. A panel of experts on bone and pediatric diseases developed a series of PICO questions that address issues related to the prevention and treatment of osteoporosis in patients on GC therapy. In accordance with the GRADE approach, we conducted a systematic review of the literature, summarized effect estimations, and classified the quality of the evidence. Then, voting and the formulation of recommendations followed. Results. Seven recommendations and six general principles were developed for GC-induced osteoporosis in the pediatric population. Conclusion. These recommendations provide guidance for clinicians who must make decisions concerning pediatric patients undergoing treatment with GC.

Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine （Part 8）： Quality Evaluation with AGREE Ⅱ and RIGHT / 中医杂志

ObjectiveTo evaluate the methodological and reporting quality of clinical practice guidelines for Chinese patent medicine （CPM） with internationally recognized tools the appraisal of guidelines for research and evaluation （AGEREE） Ⅱ and reporting items for practice guidelines in healthcare （RIGHT）， thereby providing refe-rence for the clinical application and future development of CPM guidelines. MethodsDatabases including CNKI， VIP， Wanfang and Sinomed were searched for CPM guidelines， as well as medlive.cn， websites of China Association of Chinese Medicine and Chinese Medical Association， and reference lists of the included papers. The quality of the guidelines was evaluated using the AGREE Ⅱand RIGHT tools， and consistency tests were performed using Interclass Correlation Coefficient， and descriptive analysis and chi-square test were used to analyze the reporting rate for each domain and the average score for each item. ResultsFinally， 140 CPM guidelines were included， of which 51 were disease-oriented and 89 were drug-oriented， all of which were issued by China. For 51 disease-oriented CPM guidelines， the highest average score of all six AGREE Ⅱ domains was 73.32% for clarity， and the lowest was 26.80% for application； for 89 drug-oriented CPM guidelines， the highest average score was 55.62% for scope and purpose， and the lowest was 31.32% for rigour of development. In terms of the seven domains of the RIGHT checklist， the highest reporting rate was 68.26% for background， and lowest was 27.45% for other areas regarding the disease-oriented CPM guidelines； the highest reporting rate was 61.31% for background， and the lowest was 4.49% for other areas regarding drug-oriented CPM guidelines. The average reporting rate was higher for disease-oriented than drug-oriented CPM guidelines in three domains of AGREE Ⅱ （rigour of development， clarity of presentation， editorial independence）， as well as four domains of RIGHT checklist （basic information， evidence， funding and declaration and management of interests， and other areas）. ConclusionThe overall methodology and reporting quality of the current CPM guidelines still need to be improved. It is recommended that future guideline development teams should strictly refer to the AGREE Ⅱ and RIGHT checklist， and take into account of the characteristics of CPM guidelines and relevant methodo-logical suggestions in the development and reporting of CPM guidelines， thereby guiding the clinical use of CPM in a better way.

Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine （Part 7）： Introduction and Interpretation of the Guideline Reporting Checklist / 中医杂志

The systematic and comprehensive introduction and interpretation of the Reporting Checklist of Clinical Practice Guidelines for Chinese Patent Medicines V1.0 is conducive to the presentation of high-quality clinical practice guidelines for Chinese patent medicines （CPMs）， thus improving their dissemination and use. The Reporting Checklist of Clinical Practice Guidelines for Chinese Patent Medicines V1.0 specifies the requirements for clear， complete and transparent reporting of the whole process of developing CPMs guidelines， containing 4 domains， 17 topics and 43 items， and involving the basic information， recommendations and methods of guideline development. Especially， it details the items related to the rules and regulations of the use of CPMs in the recommendations， which is helpful for improving the completeness， scientificity and practicality of the reporting of CPMs guideline.

Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine （Part 6）： Formation and Presentation of Recommendations / 中医杂志

Recommendation formation is a key component of clinical practice guidelines for Chinese patent medicine （CPM）， and should encompass the determination of the strength and direction of the recommendation， the rationale for the recommendation， and the methodology for implementing the recommendation. Recommendations can be formed through formal consensus and informal consensus. The strength and direction of recommendations for CPM guidelines should be determined by considering the quality of evidence for CPMs， the priority of the clinical questions， the pros and cons of efficacy and adverse effects， patient acceptance， the feasibility of the recommendation and the availability of resources， social fairness， economic benefits， and other influencing factors. In order to better guide guideline developers to consider these factors more rationally， this article provideed a detailed explanation of each factor in the context of the characteristics of TCM.

Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine（Part 5）： Retrieval and Synthesis of Key Information on Rational Drug Use / 中医杂志

Recommendations for Chinese patent medicine （CPM） based on key information on rational drug use are one of the important conditions for enhancing guideline enforceability as well as facilitating guideline implementation. In this study， we discussed in detail of the key information on the rational use of CPM in five aspects， which are dosage， drug discontinuation， drug-drug and drug-food interactions， safety and economy. Following the process of multi-source search， synthesis and prioritization， it is suggested to collect key information on the rational use of CPM from a multi-source search of drug instructions， policy documents， literature， and clinical experts' experiences. Then the searched information should be summarized and prioritized with the principle that taking drug instructions as the basis and other-sources information for check and supplementation. Finally， methodological recommendations for the retrieval and synthesis of key information on rational drug use in guideline recommendations has been formed.

Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine（Part 4）： Evidence Retrieval and Evaluation / 中医杂志

The retrieval and evaluation of evidence is the basis for the development of clinical practice guidelines for Chinese patent medicine. As traditional Chinese medicine has a different development trajectory and utilization characteristics from modern medicine， there is certain differences in terms of evidence composition， retrieval and integration.This paper discussed multi-source body of evidence on Chinese patent medicine based on modern evidence-based medicine and ancient medical literature， and summarized the retrieval strategy as well as the possible problems and solving methods. For different types of evidence on Chinese patent medicine， the corresponding evaluation tools have been recommended， and the order to integrate the evidence based on the quality of the evidence from high to low is suggested. Finally， a multi-source based evidence retrieval-evaluation-integration scheme for Chinese patent medicine has been formed， which will provide a methodological reference for practitioners in the development of clinical practice guidelines for Chinese patent medicine.

Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine（Part 3）： Identification of Clinical Questions / 中医杂志

The identification of clinical questions for clinical practice guidelines of Chinese patent medicine （CPM） is important for subsequent evidence retrieval， evaluation of evidence quality， formation of recommendations. This paper described a methodological proposal for the identification of clinical questions for CPM guidelines to highlight the characteristics of Chinese patent medicine and reflect its effect in specific stage of the disease. Considering four aspects， namely， the drug of Chinese patent medicine （D）， the specific disease stage （S）， comparison （C）， and specific outcome （O）， DSCO framework has been proposed to formulate the clinical questions. Multi-source information through scientific research， policy or standard documents， and clinical data are suggested for collecting clinical questions， and clear selection criteria should be set to finalize the clinical questions to be addressed by the guideline. In addition， the above process needs to be transparently and publicly reported in order to ensure the clarity and completeness of the guidelines.

Methodology for the Development of Clinical Practice Guideline for Chinese Patent Medicine（Part 1）： Development Status and Characteristics / 中医杂志

The irrational use of Chinese patent medicines （CPM） is becoming more and more prominent， which makes the demand for clinical practice guidelines of CPM gradually increase. In order to make domestic scholars understand the latest developments and existing problems of the CPM guidelines， and promote its development， this paper introduced the concept of CPM guidelines， summarized the characteristics of the two development modes， namely “taking CPM as the key” and “taking disease/syndrome as the key”， and analyzed the current methodological status of developing and reporting CPM guidelines. Based on the existed problems， three suggestions have been put forward to optimize the quality of CPM guidelines， which were clarifying the target users and scope of CPM guidelines， establishing an open and transparent mechanism of the personnel involvement and process steps， and formulating implementable and operable recommendations for the use of CPM.

Guía de Sífilis Gestacional y Congénita: perspectivas de profesionales de la salud en Bolívar (Colombia) / Guidelines on Gestational and Congenital Syphilis: insights of health professionals in Bolívar (Colombia)

Objetivos: Describir los conocimientos, la idoneidad y las prácticas respecto a la "Guía de práctica clínica (GPC) basada en la evidencia para la atención integral de la sífilis gestacional (SG) y congénita (SC)". Materiales y métodos: Estudio descriptivo de corte transversal. Incluyó médicos generales, especialistas y enfermeras que laboraban en 52 instituciones de salud en el departamento de Bolívar (Colombia) y realizan el control prenatal o la atención al neonato en el 2020. Muestreo por conveniencia. Se aplicó cuestionario digital que recolectó información sociodemográfica; evaluó conocimientos, idoneidad y prácticas sobre la "Guía de práctica clínica (GPC)" mencionada en los objetivos. Se hace análisis descriptivo. Resultados: Se incluyeron 101 trabajadores. Hay deficiencias relacionadas con la aplicación correcta del algoritmo inverso de diagnóstico (48 %) y seguimiento de SG (77 %), manejo de la paciente con antecedentes de alergias de manifestaciones sistémicas (31 %) y tratamiento de la SG (61 %) y SC (10 %). La recomendación de no aplicar prueba de penicilina en pacientes sin antecedentes de alergias sistémicas se considera poco útil (60 %). El 23 % de los trabajadores no emplea las pruebas rápidas y el 44 % de los especialistas da tratamiento para sífilis al compañero sexual. Conclusiones: Es importante intensificar las estrategias de capacitación en el personal de salud con énfasis en el personal de enfermería y, de manera urgente, empoderar a este personal en las actividades relacionadas con el control de la sífilis. Se requiere hacer nuevas y continúas evaluaciones a nivel nacional y regional de la implementación de esta guía que permitan evaluar los indicadores que contiene la estrategia de eliminación de esta enfermedad.

Objectives: To describe the knowledge, appropriateness and practices regarding the evidence-based "Clinical Practice Guidelines (CPG) for the comprehensive management of gestational syphilis (GS) and congenital syphilis (CS)". Material and methods: A descriptive, cross-sectional study including general practitioners, specialists and nurses working at 52 healthcare institutions in the Bolivar Department (Colombia) who provided prenatal control or neonatal care in 2020. Convenience sampling was used. A digital questionnaire was administered to collect sociodemographic information, assessed knowledge, appropriateness and practices in terms of the evidenced-based "Clinical Practice Guidelines (CPG)" mentioned in the objectives. A descriptive analysis followed. Results: A total of 101 workers were included. There are deficiencies associated with the correct use of the inverse algorithm of diagnosis (48 %) and GS follow-up (77 %), management of the patient with a history of systemic manifestation allergies (31 %) and treatment of GS (61 %) and CS (10 %). The recommendation of not using the penicillin test in patients with no history of systemic allergies is considered of little benefit (60 %). 23 % of the workers do not use rapid tests and 44 % of the specialists administer syphilis treatment to the sexual partner. Conclusions: It is important to intensify the training strategies for health personnel with emphasis on nurses and, as a matter of urgency, empower them in syphilis control activities. New and continuous national and regional evaluations of the implementation of these guidelines are needed to assess the indicators associated with the strategy for the elimination of this disease.

Caracterización y evaluación de adherencia al programa Get With The Guidelines en pacientes con insuficiencia cardíaca aguda en un hospital de Bogotá, 2016-2018: Cohorte HUN-ICA

Introducción: la adherencia a estándares de manejo en insuficiencia cardiaca como la iniciativa Get With the Guidelines (GWTG) de la AHA puede disminuir los reingresos y mortalidad. Objetivo: describir las características clínicas de pacientes hospitalizados por insuficiencia cardiaca aguda y evaluar la adherencia a estándares de práctica clínica del programa "Get With The Guidelines", en un hospital universitario de Bogotá. Materiales y métodos: estudio observacional de la cohorte retrospectiva HUN-ICA correspondiente a 493 pacientes adultos hospitalizados entre abril 2016 y diciembre 2018 por insuficiencia cardiaca aguda, se registraron variables clínicas, tratamiento, mortalidad, reingresos y se evaluó adherencia a estándares de calidad del programa GWTG. Resultados: 52,1 % de la población fueron mujeres con una media de edad 75 años y el 67,8 % con FEVI >40 %. La etiología más común fue hipertensiva 58,5 % y la mayor causa de descompensación infecciosa (28,8 %). Aumentó la adherencia al uso de betabloqueadores en pacientes con fracción de eyección reducida al egreso de 46 % respecto al ingreso y al uso de antagonistas de receptor mineralocorticoide en pacientes con FEVI reducida de 61,1 %. Discusión: la cohorte evaluada presentó un perfil hemodinámico, clínico y adherencia en el manejo similar a cohortes nacionales. Las dosis subóptimas de la medicación al egreso justifican la necesidad de clínicas ambulatorias de insuficiencia cardíaca. Conclusiones: Se encontró menor adherencia para uso y dosis óptimas de betabloqueadores y antagonista mineralocorticoide que la de la cohorte GWTG, con incremento del uso de terapia farmacológica entre el ingreso y el egreso hospitalario.

Introduction: adherence to management standards in heart failure such as the AHA´s Get With the Guidelines-Heart failure initiative can reduce readmissions and mortality. Objective: To describe the clinical characteristics of patients hospitalized for acute heart failure and to assess adherence to program quality standards of the Get With The Guidelines Program in a university hospital in Bogotá. Methods: observational, descriptive and retrospective HUN-ICA cohort study. 493 adult patients hospitalized for acute heart failure, between April 2016 to December 2018. Clinical variables, treatment, mortality, readmissions and adherence to program quality standards defined by the GWTG program criteria were evaluated. Results: 52,1 % of the population were women, mean age was 75 years, (67,8 %) cases of heart failure with LVEF > 40 %. The most common etiology of heart failure was hypertensive (58,5 %). The most frequent etiology of decompen- sation was infectious (28,8 %). Adherence to beta-blockers use increased in patients with reduced ejection fraction at discharge of 46 %, and to the use of mineralocorticoid receptor antagonists in 61,1 %, compared to admission. Discussion: the evaluated cohort presented a hemodynamic, clinical profile and adherence similar to colombian cohorts. Suboptimal doses of medication upon discharge justify the need for outpatient heart failure clinics. Conclusions: lower adherence for use and optimal doses of beta-blockers and mineralocorticoid receptor antagonists than GWTG cohort was found, with increased use of guidelines recommended pharmacological therapy between hospital admission and discharge.

Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment

Objectives: To summarize evidence-based pharmacological treatments and provide guidance on clinical interventions for adult patients with obsessive-compulsive disorder (OCD). Methods: The American Psychiatric Association (APA) guidelines for the treatment of OCD (2013) were updated with a systematic review assessing the efficacy of pharmacological treatments for adult OCD, comprising monotherapy with selective serotonin reuptake inhibitors (SSRIs), clomipramine, serotonin and norepinephrine reuptake inhibitors (SNRIs), and augmentation strategies with clomipramine, antipsychotics, and glutamate-modulating agents. We searched for the literature published from 2013-2020 in five databases, considering the design of the study, primary outcome measures, types of publication, and language. Selected articles had their quality assessed with validated tools. Treatment recommendations were classified according to levels of evidence developed by the American College of Cardiology and the American Heart Association (ACC/AHA). Results: We examined 57 new studies to update the 2013 APA guidelines. High-quality evidence supports SSRIs for first-line pharmacological treatment of OCD. Moreover, augmentation of SSRIs with antipsychotics (risperidone, aripiprazole) is the most evidence-based pharmacological intervention for SSRI-resistant OCD. Conclusion: SSRIs, in the highest recommended or tolerable doses for 8-12 weeks, remain the first-line treatment for adult OCD. Optimal augmentation strategies for SSRI-resistant OCD include low doses of risperidone or aripiprazole. Pharmacological treatments considered ineffective or potentially harmful, such as monotherapy with antipsychotics or augmentation with ketamine, lamotrigine, or N-acetylcysteine, have also been detailed.

Guía de práctica clínica para el manejo de la Enfermedad Renal Crónica estadíos 3b, 4 y 5 en el Seguro Social de Salud del Perú (EsSalud)

Introducción: El presente artículo resume la guía de práctica clínica (GPC) para el manejo de la enfermedad renal crónica estadíos 3b, 4 y 5 en el Seguro Social del Perú (EsSalud). Objetivo: Proveer recomendaciones clínicas basadas en evidencia para el manejo de pacientes con enfermedad renal crónica estadíos 3b, 4 y 5 en EsSalud. Métodos: Se conformó un grupo elaborador de la guía (GEG) que incluyó especialistas y metodólogos. El GEG formuló 9 preguntas clínicas. Se realizó búsquedas sistemáticas de revisiones sistemáticas y estudios primarios en PubMed entre diciembre del 2020 y agosto del 2021. Se seleccionó la evidencia para responder a las preguntas clínicas planteadas. La certeza de la evidencia fue evaluada usando la metodología Grading of Recommendations Assessment, Development, and Evaluation (GRADE). El GEG usó la metodología GRADE para revisar la evidencia y formular recomendaciones, los puntos de buena práctica clínica (BPC) y los flujogramas de manejo. Finalmente, la GPC fue aprobada con Resolución N° 88-IETSI-ESSALUD-2021. Resultados: La presente GPC abordó 9 preguntas clínicas. En base a dichas preguntas se formularon 17 recomendaciones (7 fuertes y 10 condicionales), 28 BPC, y 4 flujogramas de manejo. Conclusión: El presente artículo resume la metodología y las conclusiones basadas en evidencias de la GPC para el manejo de la Enfermedad Renal Crónica estadíos 3b, 4 y 5 en EsSalud.

Introduction: This article summarizes the clinical practice guideline (CPG) for the management of stage 3b, 4, and 5 chronic kidney disease (CKD) in the Social Security of Peru (EsSalud). Objective: To provide evidence-based clinical recommendations for the management of stage 3b, 4, and 5 CKD in EsSalud. Methods: A guideline development group (GDG) was formed, including specialists and methodologists. The GDG formulated 9 clinical questions. Systematic searches for systematic reviews and primary studies were conducted in PubMed from December 2020 to August 2021. Evidence was selected to answer the clinical questions posed. The certainty of the evidence was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. The GDG used the GRADE methodology to review the evidence and formulate recommendations, points of good clinical practice (GPC), and management flowcharts. Finally, the CPG was approved with Resolution No. 88-IETSI-ESSALUD-2021. Results: This CPG addressed 9 clinical questions. Based on these questions, 17 recommendations (7 strong and 10 conditional), 28 GPC points, and 4 management flowcharts were formulated. Conclusion: This article summarizes the methodology and evidence-based conclusions of the CPG for the management of stage 3b, 4, and 5 CKD in EsSalud.

Guidelines for Psychological Rehabilitation Intervention Combined Integrated Traditional Chinese and Western Medicine After Radical Surgery for Early and Middle Stage Colorectal Cancer / 中国实验方剂学杂志

In recent years， the incidence of colorectal cancer has been rising in China， and with the promotion of early screening and early diagnosis， most colorectal cancers are able to achieve long-term survival through timely diagnosis and treatment. Nevertheless， 30%-70% of patients with early to mid-stage colorectal cancer after radical surgery still have psychological problems such as anxiety， depression， and fear of recurrence and metastasis， and they hope to seek help from traditional Chinese medicine（TCM） treatment. In order to further standardize the integrated traditional Chinese and western medicine psychological rehabilitation interventions of stage Ⅰ-Ⅲ colorectal cancer after radical surgery， and to improve the diagnosis and treatment level， under the support of the pilot project of clinical collaboration between Chinese and western medicine for major and difficult diseases of National Administration of TCM， experts in oncology， integrated Chinese and western medicine， psychology， surgery， nursing， evidence-based medicine and other disciplines from 10 units nationwide participated in the work， led by Xiyuan Hospital，China Academy of Chinese Medical Sciences and Beijing Cancer Hospital. Based on the methodology and process of guideline development of the World Health Organization Handbook for Guideline Development and the Regulations for Group Standards of China Association of Chinese Medicine， the Guidelines for Psychological Rehabilitation Intervention Combined Integrated Traditional Chinese and Western Medicine After Radical Surgery for Early and Middle Stage Colorectal Cancer have been developed according to the current best evidence， extensive consultation with clinical experts and following the situation of current clinical practice. The guideline provides the psychological characteristics， the needs and willingness to accept psychological rehabilitation， the interventions for psychological rehabilitation， evaluation of efficacy， follow-up review， educational guidance and others of patients with stage Ⅰ-Ⅲ colorectal cancer after radical surgery. It can provide guidance for TCM（integrated Chinese and western medicine） clinicians and psychologists engaged in the psychological rehabilitation of integrated Chinese and western medicine oncology， especially for doctors in primary medical institutions.

Differences in Contents and Formation Methods of Clinical Questions in Chinese and Korean Clinical Practice Guidelines of Acupuncture-Moxibustion: Scoping Review / 中国结合医学杂志

OBJECTIVE@#To analyze the differences in the needs of users and the value orientation of clinical practice guidelines (CPGs) by comparing the contents and formation methods of clinical questions in Chinese and Korean CPGs of acupuncture-moxibustion (Acup-Mox).@*METHODS@#The full text of CPGs was systematically searched from the official websites of Chinese and Korean traditional medicine societies and Acup-Mox associations, with the topic "Acup-Mox for treating diseases" and the retrieval time up to September 28, 2022. Two researchers screened the CPGs independently, and extracted the guidelines' topics, content, quantity and formation methods of clinical questions. The quantitative data were collected by counting the frequency, and the qualitative data were classified and described by thematic analysis.@*RESULTS@#A total of 29 guidelines were included in this study, including 20 Chinese guidelines (305 questions) and 9 Korean guidelines (223 questions). The differences lie in the aspects of content and diversity, and formation method. As for content and diversity, Chinese guidelines focused mainly on the questions related to treatment such as the operation of specific intervention (86, 28.2%), efficacy of intervention (78, 25.6%), and also involving questions in diagnosis, prevention, and prognosis. While the clinical questions in Korean guidelines were concentrated to efficacy of intervention (218, 97.8%). As for formation method, in Chinese guidelines, questions were usually collected directly from clinicians, and then determined and optimized by experts. In Korean guidelines, frequently used clinical Acup-Mox interventions would be screened first. Then the expert group would set up corresponding intervention control measures so as to form clinical questions related to treatment efficacy.@*CONCLUSIONS@#The differences reflect the different needs of clinical practitioners, and the different aims or concepts in developing Acup-Mox guidelines between China and South Korea. Chinese guidelines emphasized promoting operation protocols and techniques of Acup-Mox for practical use, while Korean guidelines emphasized promoting the frequently used clinical intervention therapies. It is speculated that the guidelines from these two countries would play different roles in guiding clinical operation and supporting medical decision. In terms of formation methods of clinical questions, it is suggested to attach importance to optimizing process in formatting clinical questions to improve the clinical applicability of CPGs of Acup-Mox.

Highlights of the EASL clinical practice guidelines on sclerosing cholangitis versus the latest Chinese guideline / 临床肝胆病杂志

In 2022, the European Association for the Study of the Liver issued Clinical practice guidelines on sclerosing cholangitis. With reference to the 2017 edition of Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline (2017) and in comparison to the corresponding contents in Guidelines on the diagnosis and management of primary sclerosing cholangitis (2021) issued by Chinese Society of Hepatology, Chinese Medical Association, in 2021, this article summarizes the updates in diagnosis, treatment, monitoring, and management of special populations and analyzes the basis for updated recommendations and their guiding significance in optimizing the clinical management of primary sclerosing cholangitis (PSC). The comparative analysis shows that the new version of the guidelines is similar to the Chinese guidelines in terms of diagnosis, treatment, and follow-up, and it is worth learning from the technical details such as the recommended dose of ursodeoxycholic acid and long-term follow-up plan. Since PSC is a chronic refractory disease, the drugs recommended by current guidelines cannot delay or reverse disease progression, and there is still a lack of consensus statements on immunotherapy and screening protocols for end-stage complications, which might be the directions for further research.

Interpretation of guidelines for the prevention and treatment of chronic hepatitis B (2022 edition) / 临床肝胆病杂志

Guidelines for the prevention and treatment of chronic hepatitis B (2022 edition) are updated and revised based on the research advances in chronic hepatitis B virus infection in China and globally and the previous editions of the guidelines. This article introduces the updates in natural history and the noninvasive diagnosis and treatment of fibrosis. In particular, the guidelines further expand the indications for patients with chronic hepatitis B virus infection, clearly defines the selection of the population benefiting from interferon therapy, and strictly limits the standard of oral nucleos(t)ide analogues. Meanwhile, the guidelines also recommend more active treatment of patients with low-level viremia and children in the immune-tolerant phase. The new edition of the guidelines will provide an important basis for expanding the screening for hepatitis B virus infection, improving diagnostic rate, optimizing treatment regimens, and standardizing clinical management in China.

Implementación de la guía desarrollo y mantenimiento del liderazgo en enfermería en la universidad de chile

Liderazgo, entendido como la capacidad de influir positivamente e impulsar a un grupo hacia metas comunes haciéndoles parte e involucrados en su proceso, es una característica que se desarrolla en la propia experiencia y la formación profesional. Diversos estudios evidencian la importancia del liderazgo en el cumplimiento de metas sanitarias. Quienes tienen bajo su responsabilidad al equipo que se encuentra en primera línea de atención de personas, familia, comunidad y territorios, debiesen ser líderes. El ejercicio del liderazgo por los y las enfermeras plantea grandes desafíos. En Chile se detectan obstaculizadores estructurales y personales para su ejercicio. El objetivo de este artículo es presentar la utilidad del uso de una Guía de Enfermería Basada en Evidencia para aportar a la formación de competencias en liderazgo de estos futuros profesionales.

Leadership, understood as the ability to positively influence and drive a group towards common goals, making them part of and getting them involved in the process, is an aspect that can be developed through experience and professional training. Several studies show the importance of leadership in the achievement of health-related goals. Those who are in charge of a team that is in the first line of care provision for people, family, community and territories, should be leaders. Exercising leadership among nurses poses great challenges. Moreover, structural and personal obstacles have been detected in Chile. The objective of this article is to present the usefulness of implementing an Evidence-Based Nursing Guide to contribute to the development of leadership competencies among future nursing professionals.

A liderança, entendida como a capacidade de influenciar positivamente e conduzir um grupo em direção a objetivos comuns, tornando-os parte e envolvendo-os no processo, é uma característica que pode ser desenvolvida através da experiência e do treinamento profissional. Vários estudos demostram a importância da liderança na realização dos objetivos de saúde. Aqueles que são responsáveis pela equipe na linha de frente do atendimento às pessoas, famílias, comunidades e territórios devem ser líderes. O exercício da liderança pelos enfermeiros representa grandes desafios. Além disso, no Chile, foram detectados obstáculos estruturais e pessoais no exercício da liderança. O objetivo deste artigo é apresentar a utilidade da implementação de um Guia de Enfermagem Baseado em Evidências para contribuir com a formação de competências de liderança entre os futuros profissionais de enfermagem.

Implementación de tres guías de buenas prácticas clínicas en la escuela de enfermería de la universidad de talca, chile

El presente artículo describe el proceso de implementación de tres guías elaboradas por la Registered Nurses' Association of Ontario (RNAO) de Canadá, en el módulo enfermería en el adulto en la Escuela de Enfermería de la Universidad de Talca, proceso que se enmarca en el convenio establecido entre la Universidad de Talca y esta asociación, a través del Departamento de Enfermería de la Universidad de Chile, host leader del Programa de Guías de Buenas Prácticas Clínicas de la RNAO. Esta implementación se llevó a cabo a través de diversas metodologías de enseñanza-aprendizaje que han permitido a los estudiantes integrar y aplicar la Enfermería Basada en Evidencia en la práctica clínica y también, establecer una alianza entre la institución académica y los centros de asistencia sanitaria.

This article describes the implementation process of three guidelines developed by the Registered Nurses' Association of Ontario (RNAO) in the adult nursing module at the School of Nursing of the University of Talca. This process is part of the agreement reached between the University of Talca and this association, through the Department of Nursing of the University of Chile, Host Leader of the RNAO's Best Clinical Practice Guidelines Program. This implementation has been carried out through various teaching-learning methodologies that have allowed students to integrate and apply Evidence-Based Nursing in clinical practice and also to establish an alliance between the academic institution and health care centers.

Este artigo descreve o processo de implementação de três diretrizes desenvolvidas pela Associação de Enfermeiros Registrados de Ontario (RNAO, sigla em inglês) do Canadá no módulo de enfermagem para adultos da Escola de Enfermagem da Universidade de Talca. Esse processo faz parte do acordo estabelecido entre a Universidade de Talca e esta associação, por meio do Departamento de Enfermagem da Universidade do Chile, host leader do Programa de Boas Práticas Clínicas da RNAO. Essa implementação foi realizada por meio de várias metodologias de ensino-apredizagem que permitiram aos estudantes integrarem a Enfermagem Baseada em Evidências à prática clínica, e também estabelecer uma aliança entre a instituição académica e os centros de saúde.

Boas práticas, intervenções e resultados: um estudo comparativo entre uma casa de parto e hospitais do Sistema Único de Saúde da Região Sudeste, Brasil / Good practices, interventions, and results: a comparative study between a birthing center and hospitals of the Brazilian Unified National Health System in the Southeastern Region, Brazil / Buenas prácticas, intervenciones y resultados: un estudio comparativo entre la clínica de parto y hospitales del Sistema Único de Salud en la región Sudeste, Brasil

O objetivo deste estudo foi comparar a assistência obstétrica em uma casa de parto e em hospitais do Sistema Único de Saúde (SUS) da Região Sudeste do Brasil, considerando boas práticas, intervenções e resultados maternos e perinatais. Realizou-se um estudo transversal com dados retrospectivos comparáveis, provenientes de dois estudos sobre parto e nascimento, e amostra de 1.515 puérperas de risco habitual de uma casa de parto e hospitais públicos da Região Sudeste. Utilizou-se ponderação pelo escore de propensão para equilibrar os grupos de acordo com as covariáveis idade, raça, paridade, integridade das membranas e dilatação do colo na internação, bem como regressões logísticas para estimar razões de chance (OR) e intervalos de 95% de confiança (IC95%) entre o local de parto e desfechos. Na casa de parto, quando comparada ao hospital, as puérperas tiveram maior chance de ter acompanhante (OR = 86,31; IC95%: 29,65-251,29), se alimentar ou tomar líquidos (OR = 862,38; IC95%: 120,20-6.187,33), se movimentar (OR = 7,56; IC95%: 4,65-12,31), usar métodos não farmacológicos para alívio da dor (OR = 27,82; IC95%: 17,05-45,40) e posição verticalizada (OR = 252,78; IC95%: 150,60-423,33) e menor chance de utilizar ocitocina (OR = 0,22; IC95%: 0,16-0,31), amniotomia (OR = 0,01; IC95%: 0,01-0,04), episiotomia (OR = 0,01; IC95%: 0,00-0,02) e manobra de Kristeller (OR = 0,01; IC95%: 0,00-0,02). Ademais, na casa de parto os recém-nascidos tiveram maior chance de aleitamento exclusivo (OR = 1,84; IC95%: 1,16-2,90) e menor chance de aspiração de vias aéreas (OR = 0,24; IC95%: 0,18-0,33) e gástrica (OR = 0,15; IC95%: 0,10-0,22). A casa de parto apresenta, assim, maior oferta de boas práticas e menos intervenções na assistência ao parto e nascimento, com segurança e cuidado, sem afetar os resultados.

This study aims to compare obstetric care in a birthing center and in hospitals of the Brazilian Unified National Health System (SUS) considering good practices, interventions, and maternal and perinatal results in the Southeast Region of Brazil. A cross-sectional study was conducted with comparable retrospective data from two studies on labor and birth. A total of 1,515 puerperal women of usual risk of birthing centers and public hospitals in the Southeast region were included. Propensity score weighting was used to balance the groups according to the following covariates: age, skin-color, parity, membrane integrity, and cervix dilation at hospitalization. Logistic regressions were used to estimate odds ratios (OR) and 95% confidence intervals (95%CI) between the place of birth and outcomes. In birthing centers, compared to hospitals, the puerperal woman had a higher chance of having a companion (OR = 86.31; 95%CI: 29.65-251.29), eating or drinking (OR = 862.38; 95%CI: 120.20-6,187.33), walking around (OR = 7.56; 95%CI: 4.65-12.31), using non-pharmacological methods for pain relief (OR = 27.82; 95%CI: 17.05-45.40), being in an upright position (OR = 252.78; 95%CI: 150.60-423.33), and a lower chance of using oxytocin (OR = 0.22; 95%CI: 0.16-0.31), amniotomy (OR = 0.01; 95%CI: 0.01-0.04), episiotomy (OR = 0.01; 95%CI: 0.00-0.02), and Kristeller maneuvers (OR = 0.01; 95%CI: 0.00-0.02). Also, in birthing centers the newborn had a higher chance of exclusive breastfeeding (OR = 1.84; 95%CI: 1.16-2.90) and a lower chance of airway (OR = 0.24; 95%CI: 0.18-0.33) and gastric aspiration (OR = 0.15; 95%: 0.10-0.22). Thus, birthing centers offers a greater supply of good practices and fewer interventions in childbirth and birth care, with more safety and care without influence on the outcomes.

El objetivo de este estudio fue comparar la asistencia obstétrica entre una clínica de parto y hospitales del Sistema Único de Salud (SUS) en la región Sudeste de Brasil, teniendo en cuenta las buenas prácticas, intervenciones y resultados maternos y perinatales. Se llevó a cabo un estudio transversal con datos retrospectivos comparables de dos estudios sobre trabajo de parto y nacimiento. La muestra se compuso de 1.515 puérperas con riesgo habitual en una clínica de parto y en hospitales públicos de la región Sudeste. Se utilizó la ponderación del puntaje de propensión para equilibrar los grupos según las siguientes covariables: edad, color de la piel, paridad, integridad de las membranas y dilatación cervical en la hospitalización. La regresión logística se utilizó para estimar la razón de posibilidades (OR), y se aplicó el intervalo del 95% de confianza (IC95%) entre el lugar de parto y desenlace. En la clínica de parto en comparación con el hospital, la puérpera tenía más posibilidades de tener un acompañante (OR = 86,31; IC95%: 29,65-251,29), comer o beber líquidos (OR = 862,38; IC95%: 120,20-6.187,33), moverse (OR = 7,56; IC95%: 4,65-12,31), utilizar métodos no farmacológicos para aliviar el dolor (OR = 27,82; IC95%: 17,05-45,40), posición erguida (OR = 252,78; IC95%: 150,60-423,33), y menor posibilidad de usar oxitocina (OR = 0,22; IC95%: 0,16-0,31), amniotomía (OR = 0,01; IC95%: 0,01-0,04), episiotomía (OR = 0,01; IC95%: 0,00-0,02) y maniobras de Kristeller (OR = 0,01; IC95%: 0,00-0,02). Los recién nacidos tenían más posibilidades de recibir una lactancia exclusiva (OR = 1,84; IC95%: 1,16-2,90) y menos posibilidades de tener aspiración de vía aérea (OR = 0,24; IC95%: 0,18-0,33) y gástrica (OR = 0,15; IC95%: 0,10-0,22). La clínica de parto cuenta con una mayor oferta de buenas prácticas y menos intervenciones en la asistencia al parto y nacimiento, con seguridad y cuidado, sin afectar los resultados.

Boas práticas, intervenções e resultados: um estudo comparativo entre uma casa de parto e hospitais do Sistema Único de Saúde da Região Sudeste, Brasil / Good practices, interventions, and results: a comparative study between a birthing center and hospitals of the Brazilian Unified National Health System in the Southeastern Region, Brazil / Buenas prácticas, intervenciones y resultados: un estudio comparativo entre la clínica de parto y hospitales del Sistema Único de Salud en la región Sudeste, Brasil

O objetivo deste estudo foi comparar a assistência obstétrica em uma casa de parto e em hospitais do Sistema Único de Saúde (SUS) da Região Sudeste do Brasil, considerando boas práticas, intervenções e resultados maternos e perinatais. Realizou-se um estudo transversal com dados retrospectivos comparáveis, provenientes de dois estudos sobre parto e nascimento, e amostra de 1.515 puérperas de risco habitual de uma casa de parto e hospitais públicos da Região Sudeste. Utilizou-se ponderação pelo escore de propensão para equilibrar os grupos de acordo com as covariáveis idade, raça, paridade, integridade das membranas e dilatação do colo na internação, bem como regressões logísticas para estimar razões de chance (OR) e intervalos de 95% de confiança (IC95%) entre o local de parto e desfechos. Na casa de parto, quando comparada ao hospital, as puérperas tiveram maior chance de ter acompanhante (OR = 86,31; IC95%: 29,65-251,29), se alimentar ou tomar líquidos (OR = 862,38; IC95%: 120,20-6.187,33), se movimentar (OR = 7,56; IC95%: 4,65-12,31), usar métodos não farmacológicos para alívio da dor (OR = 27,82; IC95%: 17,05-45,40) e posição verticalizada (OR = 252,78; IC95%: 150,60-423,33) e menor chance de utilizar ocitocina (OR = 0,22; IC95%: 0,16-0,31), amniotomia (OR = 0,01; IC95%: 0,01-0,04), episiotomia (OR = 0,01; IC95%: 0,00-0,02) e manobra de Kristeller (OR = 0,01; IC95%: 0,00-0,02). Ademais, na casa de parto os recém-nascidos tiveram maior chance de aleitamento exclusivo (OR = 1,84; IC95%: 1,16-2,90) e menor chance de aspiração de vias aéreas (OR = 0,24; IC95%: 0,18-0,33) e gástrica (OR = 0,15; IC95%: 0,10-0,22). A casa de parto apresenta, assim, maior oferta de boas práticas e menos intervenções na assistência ao parto e nascimento, com segurança e cuidado, sem afetar os resultados.

This study aims to compare obstetric care in a birthing center and in hospitals of the Brazilian Unified National Health System (SUS) considering good practices, interventions, and maternal and perinatal results in the Southeast Region of Brazil. A cross-sectional study was conducted with comparable retrospective data from two studies on labor and birth. A total of 1,515 puerperal women of usual risk of birthing centers and public hospitals in the Southeast region were included. Propensity score weighting was used to balance the groups according to the following covariates: age, skin-color, parity, membrane integrity, and cervix dilation at hospitalization. Logistic regressions were used to estimate odds ratios (OR) and 95% confidence intervals (95%CI) between the place of birth and outcomes. In birthing centers, compared to hospitals, the puerperal woman had a higher chance of having a companion (OR = 86.31; 95%CI: 29.65-251.29), eating or drinking (OR = 862.38; 95%CI: 120.20-6,187.33), walking around (OR = 7.56; 95%CI: 4.65-12.31), using non-pharmacological methods for pain relief (OR = 27.82; 95%CI: 17.05-45.40), being in an upright position (OR = 252.78; 95%CI: 150.60-423.33), and a lower chance of using oxytocin (OR = 0.22; 95%CI: 0.16-0.31), amniotomy (OR = 0.01; 95%CI: 0.01-0.04), episiotomy (OR = 0.01; 95%CI: 0.00-0.02), and Kristeller maneuvers (OR = 0.01; 95%CI: 0.00-0.02). Also, in birthing centers the newborn had a higher chance of exclusive breastfeeding (OR = 1.84; 95%CI: 1.16-2.90) and a lower chance of airway (OR = 0.24; 95%CI: 0.18-0.33) and gastric aspiration (OR = 0.15; 95%: 0.10-0.22). Thus, birthing centers offers a greater supply of good practices and fewer interventions in childbirth and birth care, with more safety and care without influence on the outcomes.

El objetivo de este estudio fue comparar la asistencia obstétrica entre una clínica de parto y hospitales del Sistema Único de Salud (SUS) en la región Sudeste de Brasil, teniendo en cuenta las buenas prácticas, intervenciones y resultados maternos y perinatales. Se llevó a cabo un estudio transversal con datos retrospectivos comparables de dos estudios sobre trabajo de parto y nacimiento. La muestra se compuso de 1.515 puérperas con riesgo habitual en una clínica de parto y en hospitales públicos de la región Sudeste. Se utilizó la ponderación del puntaje de propensión para equilibrar los grupos según las siguientes covariables: edad, color de la piel, paridad, integridad de las membranas y dilatación cervical en la hospitalización. La regresión logística se utilizó para estimar la razón de posibilidades (OR), y se aplicó el intervalo del 95% de confianza (IC95%) entre el lugar de parto y desenlace. En la clínica de parto en comparación con el hospital, la puérpera tenía más posibilidades de tener un acompañante (OR = 86,31; IC95%: 29,65-251,29), comer o beber líquidos (OR = 862,38; IC95%: 120,20-6.187,33), moverse (OR = 7,56; IC95%: 4,65-12,31), utilizar métodos no farmacológicos para aliviar el dolor (OR = 27,82; IC95%: 17,05-45,40), posición erguida (OR = 252,78; IC95%: 150,60-423,33), y menor posibilidad de usar oxitocina (OR = 0,22; IC95%: 0,16-0,31), amniotomía (OR = 0,01; IC95%: 0,01-0,04), episiotomía (OR = 0,01; IC95%: 0,00-0,02) y maniobras de Kristeller (OR = 0,01; IC95%: 0,00-0,02). Los recién nacidos tenían más posibilidades de recibir una lactancia exclusiva (OR = 1,84; IC95%: 1,16-2,90) y menos posibilidades de tener aspiración de vía aérea (OR = 0,24; IC95%: 0,18-0,33) y gástrica (OR = 0,15; IC95%: 0,10-0,22). La clínica de parto cuenta con una mayor oferta de buenas prácticas y menos intervenciones en la asistencia al parto y nacimiento, con seguridad y cuidado, sin afectar los resultados.